Meta-Analysis: The Efficacy and Safety of Paricalcitol for the Treatment of Secondary Hyperparathyroidism and Proteinuria in Chronic Kidney Disease

Introduction. Previous studies have demonstrated the safety and efficacy of using Paricalcitol for the treatment of secondary hyperparathyroidism (SHPT) in patients on dialysis. The aim of the current meta-analysis was to assess the safety and efficacy of Paricalcitol for the management of SHPT in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Tianzhao, Rong, Gong, Quan, Dayong, Shu, Ying, Liang, Zhu, She, Ninglan, Liu, Manli, Yang, Bing, Cheng, Gong, Lv, Yongman, Stern, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591146/
https://www.ncbi.nlm.nih.gov/pubmed/23509710
http://dx.doi.org/10.1155/2013/320560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591146/
https://www.ncbi.nlm.nih.gov/pubmed/23509710
http://dx.doi.org/10.1155/2013/320560

Ejemplares similares